Skip navigation
IWPCT.jpg

We would like to thank the attendees of IWPCT 2018 for the numerous participation and the great contributions on our 5th International Workshop on Plasma for Cancer Treatment, which was held from March 20-21, 2018 in Greifswald, Germany.

It was a great pleasure to welcome you all in our Hanseatic city!

We are looking forward to the 6th International Workshop on Plasma for Cancer Treatment (IWPCT 2019), which will be held from April 1-3, 2019 in Antwerp, Belgium!

IWPCT2018_group_photo.jpg

The 5th International Workshop on Plasma for Cancer Treatment, organized by the Leibniz Insitute for Plasma Science and Technology and the University Medicine Greifswald, was held from March 20-21, 2018 in Greifswald, Germany.

We had about 120 participants from 21 different countries and in sum 64 contibutions, inlcuding invited talks, oral presentations and posters.

The workshop covered the following topics:

  • Plasma sources and plasma equipment used for cancer treatment
  • Plasma-cancer interactions: experiments, modeling and simulation
  • Destruction of cancer cells by plasma
  • Mechanisms of plasma selectivity towards cancer cells
  • Plasma-liquid interaction / plasma chemistry in biological liquids / plasma activated media for cancer treatment
  • Clinical and animal studies of cancer treatment by plasma

 

For more impressions of the IWPCT 2018 please visit our Youtube Channel: More

Deadlines:

Abstract

  • Abstract submission: until October 25th 2017
  • Abstract submission extended until: November 09, 2017
  • Abstract acceptance notification: after November 27th 2017

Registration

  • Early registration: October 1st 2017 - January 15th 2018
  • Late registration: January 16th - February 20th 2018

Fees:

Early registration fees:

  • Regular participants (academic and research institutions, industry and private): €300
  • Students (student ID required): €150
  • Conference dinner on Tuesday evening (@University of Greifswald): +€60

Late registration fees:

  • Regular participants (academic and research institutions, industry and private): €400
  • Students (student ID required): €200
  • Conference dinner on Tuesday evening (@University of Greifswald): +€60

Social events

  • Excursion to Stralsund "Ozeaneum" (guided tour) on Monday +€40

General Chairs

  • Hans-Robert Metelmann, Clinical Plasma Medicine, Dept. for Oral and Maxillofacial Surgery, Greifswald University Medicine
  • Klaus-Dieter Weltmann, Leibniz Institute for Plasma Science and Technology (INP)

International Scientific Committee

  • Annemie Bogaerts, Chair, University of Antwerp
  • David Graves, Co-Chair, University of California Berkeley
  • Mounir Laroussi, Old Dominion University
  • Michael Keidar, George Washington University
  • Xinpei Lu, Huazhong University of Science & Technology
  • Masaru Hori, Nagoya University
  • Eun Ha Choi, Kwangwoon University
  • Jerome Canady, US Medical Innovations LLC
  • Jonathan Sherman, George Washington University
  • Georg Isbary, Roche Pharma AG
  • Klaus-Dieter Weltmann, Leibniz Institute for Plasma Science and Technology (INP)
  • Deborah O'Connell, University of York
  • Cristina Canal, Polytechnic University of Catalonia
  • João Santos Sousa, CNRS and University of Paris-Saclay

Technical Program Committee

  • Vittorio Colombo, University of Bologna, Italy
  • Eun Ha Choi, Kwangwoon University, Korea
  • Sander Bekeschus, Leibniz Institute for Plasma Science and Technology (INP)
  • Vandana Miller, Drexel University, Philadelphia
  • Hiromasa Tanaka, Meisei University, Tokyo

Local Organizing Committee

  • Hans-Robert Metelmann, Clinical Plasma Medicine, Dept. for Oral and Maxillofacial Surgery, Greifswald University Medicine
  • Klaus-Dieter Weltmann, Leibniz Institute for Plasma Science and Technology (INP)
  • Thomas von Woedtke, Leibniz Institute for Plasma Science and Technology (INP)
  • Manuela Glawe, Leibniz Institute for Plasma Science and Technology (INP)
  • Kerstin Böttger, Dept. for Oral and Maxillofacial Surgery, Greifswald University Medicine
  • Volker Markmann, Greifswald University Hospital, Greifswald University Medicine
  • Christina Rohde, Leibniz Institute for Plasma Science and Technology (INP)
  • Sander Bekeschus, Leibniz Institute for Plasma Science and Technology (INP)
  • Charlotte Giese, Leibniz Institute for Plasma Science and Technology (INP)
  • Christin Siedler, Leibniz Institute for Plasma Science and Technology (INP)
  • Lisa Treibert, Leibniz Institute for Plasma Science and Technology (INP)
  • Hans Sawade, Leibniz Institute for Plasma Science and Technology (INP)
  • Georg Daeschlein, Department of Dermatology, Greifswald University Medicine
  • Lars Ivo Partecke, Department of General, Visceral, Thoracic and Vascular Surgery, Greifswald University Medicine

In sum we had 12 Invited Talks, 11 Contributed Oral Presentations and 2 Poster Sessions

Timetable: PDF

Detailed Program: PDF

Christian Seebauer
Oncology-Medicine
University of Greifswald, Germany

David Graves
Plasma Physics
University of California, Berkeley, USA

Eleonora Turrini
Biochemistry
University of Bologna, Italy

Endre Szili
Plasma Physics
University of South Australia

Hirokazu Hara
Biochemistry
Gifu Pharmaceutical University, Japan

Lluis Mir
Oncology-Medicine
Gustave Roussy Cancer Campus, France

Mark Kushner
Plasma Physics
University of Michigan, USA

Nagendra Kauschik
Oncology-Medicine
Kwangwoon University PBRC, Korea

Sander Bekeschus
Biology
INP Greifswald, Germany

Sylvia Dewilde
Biochemistry
University of Antwerp, Belgium

Vandana Miller
Oncology-Medicine
Drexel University, USA

With the aim of recognizing the work of students in the field of Plasma Medicine applied to cancer, the Bob Barker Best Student Paper Award was given to a student for the best poster presentation at IWPCT–2017 in Paris for the first time.

To continue this tradition, we awarded the Bob Barker Best Student Paper Award at IWPCT-2018 to Katharina Witzke for her Poster "Plasma Medical Oncology: Long-Term Results with Focus on Immunity Research".

The jury was composed of the members of the ISC and the TPC. The Award was supported by BioCon Valley GmbH.

Barker_Poster_Award.jpg

In collaboration with Elsevier, the abstracts presented at the IWPCT 2018 were published in an abstract book as a supplement to Volume 9 of the Journal Clinical Plasma Medicine.

neoplas tools GmbH

neoplas tools GmbH is a spin-off of the Leibniz Institute for Plasma Science and Technology (INP Greifswald). Since 2013 our company has been following an innovative approach to establish the application of cold physical plasma via a jet procedure as a new therapy method in medicine. Together with science we are working continuously on the further development of cold plasma therapy solutions in medical technology. Our kINPen® MED is the first CE certified atmospheric pressure plasma jet with a medical device approval for the treatment of chronic wounds and pathogen-induced diseases of the skin. This new and effective type of treatment supports wound healing and has proven to be an effective supplement to standard wound management.

Leibniz Health Technologies

Concrete technology solutions for urgent medical needs − this is the main focus of the 14 member institutes of the research alliance Leibniz Health Technologies. Together, they are pursuing the goal of improving medical care for patients. Using an interdisciplinary approach prevention, diagnosis and therapy shall grow together and thus increase the quality of life. The partners in the Leibniz Research Alliance “Health Technologies” have defined five interdisciplinary competence areas as central research pillars: Point-of-Care Technologies / Imaging Methods / Biomarkers /Plasma Medicine /Bioactive Materials. Those competence areas pursue a common goal: To apply results of fundamental research as quickly and efficiently as possible for use as medical technologies. In close coordination with industry, hospitals, insurance companies and politicians the research alliance develops health care technologies that are brought to market along a seamless innovation chain. In parallel, Leibniz Health Technologies investigates the social and economic consequences of new medical technologies in order to optimize their usefulness for the user and to create broad social acceptance for new technologies.

 

Kontakt

Leibniz-Institut für Plasmaforschung und Technologie e.V.
Felix-Hausdorff-Str. 2
17489 Greifswald

Stefan Gerhardt
Kommunikation

Tel.: +49 3834 - 554 3903
Fax: +49 3834 - 554 30

stefan.gerhardtinp-greifswaldde
www.leibniz-inp.de

Stefan_Gerhardt_sw_klein.jpg
gerhardt.jpg